Agmatine
From Wikipedia, the free encyclopedia
Agmatine | |
---|---|
IUPAC name | 2-(4-Aminobutyl)guanidine |
Other names | (4-Aminobutyl)guanidine |
Identifiers | |
CAS number | [306-60-5] |
PubChem | |
SMILES | C(CCN=C(N)N)CN |
Properties | |
Molecular formula | C5H14N4 |
Molar mass | 130.19 g mol-1 |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
Agmatine ((4-aminobutyl)guanidine, NH2-CH2-CH2-CH2-CH2-NH-C(-NH2)(=NH)) is the decarboxylation product of the amino acid arginine and is an intermediate in polyamine biosynthesis. It is discussed as a putative neurotransmitter. It is synthesized in the brain, stored in synaptic vesicles, accumulated by uptake, released by membrane depolarization, and inactivated by agmatinase. Agmatine binds to α2-adrenergic receptor and imidazoline binding sites, and blocks NMDA receptors and other cation ligand-gated channels. Agmatine inhibits nitric oxide synthase (NOS), and induces the release of some peptide hormones.
Contents |
[edit] Clinical significance
Treatment with exogenous agmatine exerts neuroprotective effects in animal models of neurotrauma.
[edit] History
The term "agmatine" was coined in 1910 by Albrecht Kossel, the German scientist who first identified the substance in herring sperm.[1]
[edit] See also
[edit] References
- ^ Kossel, Albrecht 1910. Über das Agmatin. Zeitschrift für Physiologische Chemie 66: 257-261
- Jae-Hwan Kim, et al. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Experimental Neurology. 189 (2004) 122– 130
- Sa-Hyun Kim. Regulation of subventricular zone stem cell proliferation and differentiation by agmatine. Graduate School, Yonsei University. (2006) article
|